ConcertAI
Key Highlights
- ConcertAI leverages predictive and generative AI to provide research-ready data and advanced technologies for healthcare and life sciences.
- The company's partnerships with over 46 leading biomedical innovators and 2,000 healthcare providers enhance its ability to deliver high-quality, research-backed solutions.
- TeraRecon® and CancerLinQ® are key components of ConcertAI's offerings, providing specialized AI solutions for radiological imaging and oncology care.
- ConcertAI's mission-driven approach focuses on accelerating insights and outcomes for patients through AI-driven research and data analysis.
- The company's commitment to scientific expertise and regulatory alignment ensures its solutions meet the highest standards in the healthcare industry.
About ConcertAI
ConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Founded in 2018, ConcertAI partners with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies to accelerate insights and outcomes for patients. The company leverages research-ready data, CARAai™ technologies, and scientific expertise to deliver quality solutions. TeraRecon® offers advanced radiological image visualizations and clinical AI decision augmentation for MRI and CT, while CancerLinQ® provides oncology providers with ASCO-aligned automated QOPI and ASCO Certified® quality solutions and SmartLinQ™ analytic services.
ConcertAI's mission is to transform healthcare through AI-driven insights and data-centric research. The company's innovative approach combines advanced AI technologies with extensive real-world data to support clinical decision-making and improve patient outcomes. By fostering partnerships with key industry players, ConcertAI ensures its solutions are aligned with the latest scientific advancements and regulatory standards.
Based in Cambridge, Massachusetts, ConcertAI employs 823 professionals dedicated to advancing the field of AI in healthcare. The company's strategic initiatives and commitment to excellence make it a pivotal player in the healthcare technology sector. ConcertAI's comprehensive solutions address the complex needs of the healthcare industry, positioning it as a leader in AI-driven healthcare innovation.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
Technology Stack
- AI
- SaaS
Office Locations
- 501 Boylston Street, Boston
Why Contact ConcertAI?
B2B professionals should contact ConcertAI for access to cutting-edge AI solutions and real-world data research in healthcare. The company's extensive partnerships and innovative technologies make it an ideal partner for vendors, recruiters, and sales teams seeking to leverage AI in healthcare.
Who Should Contact ConcertAI for Business?
Sales teams selling AI solutions, recruiters seeking roles in healthcare technology, and partners offering advanced data analytics and AI capabilities should reach out to ConcertAI.
Categories
- AI in healthcare
- Real-world data
- Predictive AI
- Generative AI
- Radiological imaging
- Oncology care
- Clinical decision support
- Medical research
- Healthcare innovation
- Data analytics
More Healthcare Technology Companies
Frequently Asked Questions
- Who is the CEO of ConcertAI?
- Eron Kelly is the Chief Executive Officer of ConcertAI, having recently succeeded founding CEO Dr. Jeff Elton.
- What does ConcertAI do?
- ConcertAI is an AI-powered SaaS company that leverages real-world data and advanced AI to accelerate drug development and improve patient outcomes, particularly in the field of oncology.
- How many employees does ConcertAI have?
- ConcertAI has approximately 450 total employees.
- Where is ConcertAI headquartered?
- ConcertAI is headquartered in Massachusetts, with primary locations listed in Cambridge and Boston.
- What industry is ConcertAI in?
- ConcertAI operates in Healthcare Technology, AI Services, Medical Research.
- When was ConcertAI founded?
- ConcertAI was founded in 2018.
- Is ConcertAI still active?
- Yes, ConcertAI was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to ConcertAI?
- Research ConcertAI's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to ConcertAI?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with ConcertAI